Supernus Pharmaceuticals Other Operating Expenses (Quarterly) Analysis

Supernus Pharmaceuticals, Inc. (SUPN)

51.81 +0.36 (+0.70%) USD | NASDAQ | Jan 14, 16:00

51.71 -0.10 (-0.19%) After-Hours: 20:00

View Other Operating Expenses (Quarterly) for SUPN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Operating Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Operating Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Operating Expenses (Quarterly) Benchmarks

Start Trial

Amphastar Pharmaceuticals, Inc.	--
BridgeBio Pharma, Inc.	--
Catalyst Pharmaceuticals, Inc.	--
Assembly Biosciences, Inc.	--
Viking Therapeutics, Inc.	--